Effects of CYP1A2 on disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,4,7,8-pentachlorodibenzofuran, and 2,2',4,4',5,5'-hexachlorobiphenyl in CYP1A2 knockout and parental (C57BL/6N and 129/Sv) strains of mice

Toxicology and Applied Pharmacology

Volumn 159, Issue 1, 1999, Pages 52-64

  Diliberto, Janet J ^a   Burgin, Deborah E ^b   Birnbaum, Linda S ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; BINDING PROTEIN; BIPHENYL DERIVATIVE; DIBENZOFURAN DERIVATIVE; PHENACETIN O DEETHYLASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KNOCKOUT MOUSE; LIVER; MOUSE; MOUSE STRAIN; NONHUMAN; TISSUE DISTRIBUTION;

EID: 0033566691     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8720     Document Type: Article

References (75)

1. Abraham K., Krowke R., Neubert D. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection. Arch. Toxicol. 62:1988;359-368.
2. Ahlborg U. G., Becking G. C., Birnbaum L. S., Brouwer A., Derks H. J. G. M., Feeley M., Golor G., Hannberg A., Larsen J. C., Liem A. K. D., Safe S. H., Schlatter C., Waern F., Younes M., Yrjanheikki E. Toxic equivalency factors for dioxin-like PCBs. Chemosphere. 28:1994;1049-1067.
3. Batra R., DeVito M., Birnbaum L. S. Role of Ah receptor in the induction of cytochrome P450 1A1 and 1A2 enzymes in response to TCDD exposure. Toxicologist. 14:1994;408.
4. Beebe L. E., Fornwald L. W., Alworth W. L., Dragnev K. H., Lubet R. A. Effect of dietary Aroclor 1254 exposure on lung and kidney cytochromes P450 in female rats: Evidence for P4501A2 expression in kidney. Chemico-Biol. Interact. 97:1995;215-227.
5. Berthou F., Flinois J. P., Ratanasavanh D., Beaune P., Riche C., Guillouzo A. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes. Drug. Metab. Dispos. Biol. Fate Chem. 19:1991;561-567.
6. Birnbaum L. S. The mechanism of dioxin toxicity: Relationship to risk assessment. Environ. Health Perspect. 102:1994;157-167.
7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
8. Brewster D. W., Birnbaum L. S. Disposition and excretion of 2,3,4,7,8-pentachlorodibenzofuran in the rat. Toxicol. Appl. Pharmacol. 90:1987;243-252.
9. Butler M. A., Iwasaki M., Guengerich F. P., Kadlubar F. F. Human cytochrome P450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Cancer Res. 49:1989;25-31.
10. Butler M. A., Lang N. P., Young J. F., Caporaso N. E., Vineis P., Hayes R. B., Teitel C. H., Massengill J. P., Lawsen M. F., Kadlubar F. F. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics. 2:1992;116-127.
11. Crespi C. L., Penman B. W., Gelboin H. V., Gonzalez F. J. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis. 12:1991;1197-1201.
12. Czerwinski M., McLemore T. L., Philpot R. M., Nhamburo P. T., Korzekwa K., Gelboin H. V., Gonzalez F. J. Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: Evidence for species-specific metabolism. Cancer Res. 51:1991;4636-4648.
13. DeVito M. J., Birnbaum L. S. Toxicology of the dioxins and related chemicals. Schecter A. Dioxins and Health. 1994;139-162 Elsevier, New York.
14. DeVito M. J., Birnbaum L. S. The importance of pharmacokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran. Fundam. Appl. Toxicol. 24:1995;145-148.
15. DeVito M. J., Diliberto J. J., Ross D. G., Menache M. G., Birnbaum L. S. Dose-response relationships for polyhalogenated dioxins and dibenzofurans following subchronic treatment in mice: 1. CYP1A1 and CYP1A2 enzyme activity in liver, lung and skin. Toxicol. Appl. Pharmacol. 147:1997;267-280.
16. DeVito M. J., Maier W. E., Diliberto J. J., Birnbaum L. S. Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment. Fundam. Appl. Toxicol. 20:1993;125-130.
17. DeVito M. J., Ma X., Babish J. G., Menache M., Birnbaum L. S. Dose response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor and protein tyrosine phosphorylation. Toxicol. Appl. Pharmacol. 124:1994;82-90.
18. DeVito M. J., Ross D. R., Birnbaum L. S. Disposition of PCDD/PCDF in mice. Organohalogen Compounds. 25:1995;11-15.
19. DeVito M. J., Ross D. G., Dupuy A. E. Jr., Ferrario J., McDaniel D., Birnbaum L. S. Dose-response relationships for disposition and hepatic sequestration of polyhalogenated dibenzo-p-dioxins, dibenzofurans, and biphenyls following subchronic treatment in mice. Toxicol. Sci. 46:1998;223-234.
20. Diliberto J. J., Akubue P. I., Luebke R. W., Birnbaum L. S. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Toxicol. Appl. Pharmacol. 130:1995;197-208.
21. Diliberto J. J., Burgin D., Birnbaum L. S. Role of CYP1A2 in hepatic sequestration of dioxin: Studies using CYP1A2 knock-out mice. Biochem. Biophys. Res. Commun. 236:1997;431-433.
22. Diliberto J. J., Jackson J. A., Birnbaum L. S. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) disposition following pulmonary, oral, dermal, and parenteral exposures to rats. Toxicol. Appl. Pharmacol. 138:1996;158-168.
23. Farin F. M., Omiecinski C. J. Regiospecific expression of cytochrome P450s and microsomal epoxide hydrolase in human brain tissue. J. Toxicol. Environ. Health. 40:1993;323-341.
24. Farin F. M., Pohlman T. H., Omiecinski C. J. Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicol. Appl. Pharmacol. 124:1994;1-9.
25. Fingerhut M. A., Halperin W. E., Marlow D. A., Placitelli L. A., Honchar P. A., Sweeny M. H., Gireife A. L., Dill P. A., Steenland K., Suruda A. J. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N. Engl. J. Med. 324:1991;212-218.
26. 1. Cancer Res. 54:1994;101-108.
27. Gillner M., Brittebo E. B., Brandt I., Söderkvist P., Appelgren L-B., Gustafsson J-Å. Uptake and specific binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Res. 47:1987;4150-4159.
28. Goldstein J. A., Linko P. Differential expression of two 2,3,7,8-tetrachlorodibenzo-p-dioxin inducible forms of cytochrome P-450 in extrahepatic versus hepatic tissues. Mol. Pharmacol. 25:1984;185-191.
29. 3-450 mRNA levels by 3-methylcholanthrene. Mol. Pharmacol. 26:1984;117-121.
30. Gonzalez F. J., Fernandez-Salguero P., Lee S. S. T., Pineau T., Ward J. M. Xenobiotic receptor knockout mice. Toxicol. Lett. 82/83:1995;117-121.
31. Gupta M., Miggens J., Parrish A., Womack J., Ramos K. S., Rodriguez L. V., Goldstein L. S., Holtzapple C., Stanker L., Safe S. H. Ah receptor-independent induction of CYP1A2 gene expression in genetically inbred mice. Environ. Toxicol. Pharmacol. 5:1998;205-213.
32. Hamm J. T., Ross D. G., Richardson V. M., Diliberto J. J., Birnbaum L. S. Methoxyresorufin: An inappropriate substrate for CYP1A2 in the mouse. Biochem. Pharmacol. 56:1998;1657-1660.
33. Holsapple M. P., Matulka R. A., Jordan S. D., Park S. S., Jeong T. C. SKF 525-A induces cocaine N-demethylase, ethoxyresorufin O-deethylase and pentoxyresorufin O-dealkkylase activities by induction of cytochrome P450 2B in female B6C3F1 mice. Toxicologist. 30:1996.
34. Jackson J. A., Diliberto J. J., Birnbaum L. S. Estimation of octanol-water partition coefficients and correlation with dermal absorption for several polyhalogenated aromatic hydrocarbons. Fundam. Appl. Toxicol. 21:1993;334-344.
35. Jackson J. A., Birnbaum L. S., Diliberto J. J. Effects of age, sex, and pharmacologic agents on the biliary elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in F344 rats. Drug Metab. Dispos. 26:1998;714-719.
36. Jensen A. A. Polychlorobiphenyls (PCBs), polychlorodibenzo-p-dioxins (PCDDs) and polychlorodibenzofurans (PCDFs) in human milk, blood and adipose tissue. Sci. Total Environ. 64:1987;259-293.
37. Kedderis L. B., Diliberto J. J., Linko P., Goldstein J. A., Birnbaum L. S. Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: Biliary excretion and induction of cytochromes CYP1A1 and CYP1A2. Toxicol. Appl. Pharmacol. 111:1991;163-172.
38. Kedderis L. B., Mills J. J., Andersen M. E., Birnbaum L. S. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: Tissue distribution and CYP1A induction. Toxicol. Appl. Pharmacol. 121:1993;87-98.
39. 3-450 genes: Differential transcriptional activation and mRNA stability in liver and extrahepatic tissues. Mol. Cell. Biol. 6:1986;1471-1477.
40. King F. G., Dedrick R. L., Collins J. M., Matthews H. B., Birnbaum L. S. Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species. Toxicol. Appl. Pharmacol. 67:1983;390-400.
41. Kuroki J., Koga N., Yoshimura H. High affinity of 2,3,4,7,8-pentachlorodibenzofuran to cytochrome P-450 in the hepatic microsomes of rats. Chemosphere. 15:1986;731-738.
42. Lahvis G. P., Bradfield C. A. Ahr null alleles: Distinctive or different? Biochem. Pharmacol. 56:1998;781-787.
43. Liang H. C. L., Li H., McKinnon R. A., Duffy J. J., Potter S. S., Puga A., Nebert D. W. Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. Proc. Natl. Acad. Sci. USA. 93:1996;1671-1676.
44. Liu G., Gelboin H. V., Myers M. J. Role of cytochrome P450 1A2 in acetanilide 4-hydroxylation as determined with cDNA expression and monoclonal antibodies. Arch. Biochem. Biophys. 284:1991;400-406.
45. McDonnell W. M., Scheiman J. M., Traber P. G. Induction of cytochrome P450IA genes (CYP1A) by omeprazole in the human alimentary tract. Gastroenterology. 103:1992;1509-1516.
46. NTP (US National Toxicology Program), 1982, Carcinogenesis bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin (case no 1746-01-5) in Osborne-Mendel-rats and B6C3F1 mice (gavage study), US Government Printing Office, Washington, (DHHS publication NIH 82-1765.
47. Olson J. R., Gasiewicz T. A., Neal R. A. Tissue distribution, excretion, and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the Golden Syrian Hamster. Toxicol. Appl. Pharmacol. 56:1980;78-85.
48. Pineau T., Fernandez-Salguero P., Lee S. S. T., McPhail T., Ward J. M., Gonzalez F. J. Neonatal lethality associated with respiratory distress in mice lacking cytochrome P4501A2. Proc. Natl. Acad. Sci. USA. 92:1995;5134-5138.
49. Pleuss N., Poiger H., Schlatter C. The metabolism of some pentachlorodibenzofurans in the rat. Xenobiotica. 17:1987;209-219.
50. Pohl R. A., Fouts J. R. A rapid method for asaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal. Biochem. 107:1981;150-155.
51. Poiger H., Buser H-R., Weber H., Zweiger U., Schlatter C. Structure elucidation of mammalian TCDD metabolites. Experimenta. 38:1982;484-486.
52. Poland A., Glover E. Genetic expression of aryl hydrocarbon hydroxylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Evidence for a receptor mutation in genetically non-responsive mice. Mol. Pharmacol. 11:1975;389-398.
53. 125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: Characterization and identification. Mol. Pharmacol. 36:1989a;113-120.
54. 125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonists for the Ah receptor. Mol. Pharmacol. 36:1989b;121-127.
55. Quattrochi L. C., Tukey R. H. The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene. Mol. Pharmacol. 36:1989;66-71.
56. Quattrochi L. C., Vu T., Tukey R. H. The human CYP1A2 gene and induction by 3-methylcholanthrene. J. Biol. Chem. 269:1994;6949-6954.
57. Ramsey J. C., Hefner J. G., Karbowski R. J., Braun W. H., Gehring P. J. The in vivo biotransformation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat. Toxicol. Appl. Pharmacol. 65:1982;180-184.
58. Raucey J. L., Lasker J. M., Lieber C. S., Black M. Acetamenophen activation by human liver cytochrome P450IIE1 and P4501A2. Arch. Biochem. Biophys. 271:1989;270-283.
59. Ryu D.-Y., Levi P. E., Fernandez-Salguero P., Gonzalez F. J., Hodgson E. Piperonyl butoxide and acenaphthylene induce CYP1A2 and CYP1B1 mRNA in Ah receptor knock-out (AHR-/-) mouse liver. Mol. Pharmacol. 50:1996;443-446.
60. Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). CRC Crit. Rev. Toxicol. 21:1990;51-58.
61. Santostefano M. J., Birnbaum L. S., Diliberto J. J. CYP1A2 knockout mice: Decreased hepatic microsomal localization of TCDD. Organohalogen Compounds. 34:1997;380-385.
62. Santostefano M. J., Little K. M., Whisnant N. A., Richardson V. M., DeVito M. J., Diliberto J. J., Birnbaum L. S. Subcellular localization of TCDD differs between the liver, lungs and kidneys after acute and subchronic exposure: Species/dose comparisons and possible mechanism. Fundam. Appl. Toxicol. 34:1996;265-275.
63. Sawahata T., Olson J. R., Neal R. A. Identification of metabolites of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) formed on incubation with isolated rat hepatocytes. Biochem. Biophys. Res. Commun. 105:1982;341-346.
64. Schilter B., Omiecinski C. J. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Molecul. Pharmacol. 44:1993;990-996.
65. Schweikl H., Taylor J. A., Kitareewan S., Linko P., Nagorney D., Goldstein J. A. Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics. 3:1993;239-249.
66. Sesardic D., Cole K. J., Edwards R. J., Davies D. S., Thomas P. E., Levin W., Boobis A. R. The inducibility and catalytic activity of cytochromes P450c (P4501A1) and P450d (P4501A2) in rat tissues. Biochem. Pharmacol. 39:1990;499-506.
67. Shimada T., Iwasaki M., Martin M. V., Guengerich F. P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK 1002. Cancer Res. 49:1989;3218-3228.
68. Sonnier M., Cresteil T. Delayed ontogenesis of CYP1A2 in the human liver. Eur. J. Biochem. 251:1998;893-898.
69. Thoma H., Mucke W., Kauert G. Comparison of the polychlorinated dibenzo-p-dioxin and dibenzofuran in human tissue and human liver. Chemosphere. 20:1990;433-442.
70. van Birgelen A. P. J. M., Ross D. G., DeVito M. J., Birnbaum L. S. Interactive effects between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,2′,4,4′,5,5′-hexachlorobiphenyl in female B6C3F1 mice: Tissue distribution and tissue-specific enzyme induction. Fundam. Appl. Toxicol. 34:1996;118-131.
71. Van den Berg M., Bouwman C., Seinen W. Hepatic retention of PCDDs and PCDFs in C57B1/6 and DBA/2 mice. Chemosphere. 19:1989;795-802.
72. Van den Berg M., de Jongh J., Poiger H., Olson J. R. The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. CRC Crit. Rev. Toxicol. 24:1994;1-74.
73. Voorman R., Aust S. D. Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity. Toxicol. Appl. Pharmacol. 90:1987;69-78.
74. Voorman R., Aust S. D. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) is a tight binding inhibitor of cytochrome P450-d. J. Biochem. Toxicol. 4:1989;105-109.
75. Zaher H., Yang T. J., Gelboin H. V., Fernandez-Salguero P., Gonzalez F. J. Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-null mouse. Biochem. Pharmacol. 55:1998;235-238.